Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT01864746
- GBG78/BIG 1-13/NSABP-B-54-I, 2013-001040-62, ANZ 1402, NC100
Trial sponsor
German Breast Group
Scientific Title
Phase III Study Evaluating Palbociclib (PD-0332991), a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor in Patients With Hormone-receptor-positive, HER2-normal Primary Breast Cancer With High Relapse Risk After Neoadjuvant Chemotherapy.